These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 604096)

  • 21. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus].
    Crifò S; Filiaci F; Pelosio A; Rocchi G
    Boll Soc Ital Biol Sper; 1978 Jun; 54(11):1021-6. PubMed ID: 743410
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine].
    Bergamini F; Profeta ML; Ferroni P; Zanetti AR
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):1-12. PubMed ID: 1021151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness.
    Bizanov G; Janakova L; Knapstad SE; Karlstad T; Bakke H; Haugen IL; Haugan A; Samdal HH; Haneberg B
    Scand J Immunol; 2005 Jun; 61(6):503-10. PubMed ID: 15963044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response to one and two doses of influenza virus subunit vaccine.
    Feery BJ; Cheyne IM; Hampson AW; Atkinson MI
    Med J Aust; 1976 Feb; 1(7):186, 188-9. PubMed ID: 1272148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
    Tamura SI; Kurata T
    Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
    Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.
    Asanuma H; Fujihashi K; Miyakoshi T; Yoshikawa T; Fujita-Yamaguchi Y; Kojima N; Nakata M; Suzuki Y; Tamura S; Kurata T; Sata T
    Vaccine; 2007 Sep; 25(39-40):6975-80. PubMed ID: 17716790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines.
    Shvartsman YS; Agranovskaya EN; Zykov MP
    J Infect Dis; 1977 May; 135(5):697-705. PubMed ID: 858947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and serologic effects of live attenuated serum inhibitor-resistant influenza B vaccine in seronegative adults.
    Miller LW; Togo Y; Hornick RB
    J Med Virol; 1977; 1(3):193-9. PubMed ID: 344835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgE and IgE antibody to mite in nasal fluid.
    Okuda M
    ORL J Otorhinolaryngol Relat Spec; 1975; 37(6):344-55. PubMed ID: 1239705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine.
    Smith-Norowitz TA; Wong D; Kusonruksa M; Norowitz KB; Joks R; Durkin HG; Bluth MH
    Int J Med Sci; 2011 Mar; 8(3):239-44. PubMed ID: 21448311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination.
    Wenzel RP; Hendley JO; Sande MA; Gwaltney JM
    JAMA; 1973 Oct; 226(4):435-8. PubMed ID: 4800234
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical study of IgE. (continued report)--dermatomucous reaction of anti-IgE serum].
    Okuda M; Kin Y; Sekine K
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):298-9. PubMed ID: 4937558
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of antibodies in the blood serum and secretions of the respiratory tract in resistance to influenza infection].
    El'kin VM; Zlydnikov DM; Agranovskaia EN; Shvartsman IaS; Mal'tseva AI
    Klin Med (Mosk); 1975 Feb; 53(2):82-5. PubMed ID: 1186068
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum antibodies and local antibodies after subcutaneous or intranasal influenza vaccination].
    Nicolas A; Pasquier P; Peyron L; Triau R; Werner GH
    C R Acad Hebd Seances Acad Sci D; 1973 Jul; 277(4):467-9. PubMed ID: 4206634
    [No Abstract]   [Full Text] [Related]  

  • 40. Urticaria subsequent to administration of influenza vaccine.
    Horowitz L
    South Med J; 1979 Oct; 72(10):1334-5. PubMed ID: 482996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.